Sepse: Critical Analysis of New Sepse Definitions and Retrospective Evaluation of Sepse Protocol at a Tertiary Hospital in Brazil

NCT ID: NCT03217981

Last Updated: 2017-08-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

506 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-08-02

Study Completion Date

2017-08-08

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Research in the databases Lilacs, BIREME, SciELO by the terms: systemic inflammatory response syndrome (SIRS), sepsis, severe sepsis and septic shock and their equivalents in the English language. Selection of the main articles of the last five years to study and contextualize the reality presented since the implantation of the HUVR sepsis protocol. Statistical analysis of data since the implementation of the sepsis protocol in the HUVR, in July 2014 until June 2016.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sepsis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

2015

2015 - Individuals with a diagnosis of sepsis from June 2014 to May 2015

Sepsis protocol

Intervention Type OTHER

Adherence to the sepsis protocol

2016

2016 -Individuals with a diagnosis of sepsis from June 2015 to May 2016

Sepsis protocol

Intervention Type OTHER

Adherence to the sepsis protocol

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Sepsis protocol

Adherence to the sepsis protocol

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

All individuals who had a confirmed or suspected sepsis diagnosis and had a sepsis protocol completed during the study period.

\-

Exclusion Criteria

Individuals with confirmed or suspected sepsis in the study period who did not complete the protocol.

Individuals under the age of 18

\-
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Unimed Volta Redonda

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Vicente Lopes da Silva Junior

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Leila Auler

Role: STUDY_DIRECTOR

Director

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Vicente Lopes

Volta Redonda, Rio de Janeiro, Brazil

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Brazil

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Vicente L da Silva Jr

Role: CONTACT

+5521981227376

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Vicente Lopes

Role: primary

+5521981227376

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HUVR17.1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Renal Resistive Index in Septic Shock Patients
NCT06214715 ACTIVE_NOT_RECRUITING